Perspective Therapeutics Inc
AMEX:CATX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Perspective Therapeutics Inc
AMEX:CATX
|
US |
|
F
|
Flexdeal SIMFE SA
ELI:FLEXD
|
PT |
|
Banco Santander SA
F:BSDK
|
ES |
|
Trio-Tech International
NASDAQ:TRT
|
US |
|
M
|
Marti Technologies Inc
AMEX:MRT
|
US |
|
N
|
Novartis AG
DUS:NOT
|
CH |
|
I
|
Intops Co Ltd
KOSDAQ:049070
|
KR |
|
M
|
Mega Lifesciences PCL
SET:MEGA
|
TH |
|
PTT PCL
OTC:PUTRY
|
TH |
|
MPC Container Ships ASA
OSE:MPCC
|
NO |
|
Konoike Transport Co Ltd
F:2KT
|
JP |
|
Itway SpA
F:IW3
|
IT |
|
S
|
Shangri-La Hotel PCL
SET:SHANG
|
TH |
|
G
|
Groupe Tera SA
PAR:ALGTR
|
FR |
|
CJ Corp
KRX:001040
|
KR |
|
F
|
Filtronic PLC
XMUN:FTI
|
UK |
|
C
|
Cassiar Gold Corp
F:756
|
CA |
|
S
|
Sonoro Energy Ltd
OTC:SNVFF
|
CA |
|
M
|
Manx Financial Group PLC
F:3IM
|
IM |
|
P
|
PMC Label Material PCL
SET:PMC
|
TH |
|
C
|
Cresud SACIF y A
F:CD8
|
AR |
|
R
|
Ratchthani Leasing PCL
SET:THANI
|
TH |
|
B
|
Boeing Co
F:BCO
|
US |
|
R
|
Regions Financial Corp
F:RN7
|
US |
Bankruptcy Probability
Perspective Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Perspective Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
P
|
Perspective Therapeutics Inc
AMEX:CATX
|
303.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
488.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
224.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
187.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
129.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
89.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
57.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Perspective Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Perspective Therapeutics Inc has total debt of 1.5m USD. This includes both short-term (0 USD) and long-term (1.5m USD) debt.
You can find a full breakdown on its Balance Sheet.